Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  RaySearch Laboratories AB (publ)    RAY B   SE0000135485

RAYSEARCH LABORATORIES AB (PUBL)

(RAY B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

RaySearch Laboratories publ : Bulletin from the Annual General Meeting 2020

share with twitter share with LinkedIn share with facebook
06/30/2020 | 10:43am EDT

At the Annual General Meeting of RaySearch Laboratories AB (publ) held today, the following resolutions were adopted.

It was resolved to re-elect Carl Filip Bergendal, Johan Löf, Britta Wallgren, Hans Wigzell, Lars Wollung and Johanna Öberg as board members of the company and to re-elect Lars Wollung as chairman of the board.

The Annual General Meeting adopted the balance sheets and income statements and discharged the members of the board and the CEO from liability. It was resolved that the accumulated profit, amounting to SEK 206,198,000 be brought forward and balanced in the new accounts.

It was resolved to adopt the guidelines for remuneration to senior executives proposed by the board.

It was resolved that remuneration to board members who do not receive a salary from any Group company shall amount to SEK 700,000 to the chairman of the board and SEK 250,000 to each of the other board members elected by the general meeting.

It was resolved that the auditor's fees be paid in accordance with approved invoicing and to re-elect the auditing firm Ernst & Young as auditor.

The Annual General Meeting also approved the board's proposal regarding amendments of the articles of association.

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Peter Thysell, CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com
 

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch's software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

More information about RaySearch is available at www.raysearchlabs.com

* Subject to regulatory clearance in some markets.

https://news.cision.com/raysearch-laboratories/r/bulletin-from-the-annual-general-meeting-2020,c3145657

https://mb.cision.com/Main/1102/3145657/1272447.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English


share with twitter share with LinkedIn share with facebook
All news about RAYSEARCH LABORATORIES AB (PUBL)
09/16RAYSEARCH LABORATORIES : Cutting-edge cancer treatment comes to Belgium with the..
AQ
08/28RAYSEARCH LABORATORIES : RayStation in clinical use at both of Spain's proton ce..
AQ
08/26RAYSEARCH LABORATORIES : Interim report January 1 - June 30, 2020
AQ
07/15RAYSEARCH LABORATORIES PUBL : and TAE Life Sciences announce agreement on RaySta..
AQ
07/09RAYSEARCH LABORATORIES PUBL : Further clinical implementation of deep learning s..
AQ
06/30RAYSEARCH LABORATORIES PUBL : Bulletin from the Annual General Meeting 2020
AQ
06/29RAYSEARCH LABORATORIES PUBL : Machine learning algorithm from RaySearch enhances..
AQ
06/29RAYSEARCH LABORATORIES PUBL : Pioneering oncology information system RayCare 4A ..
AQ
06/24RAYSEARCH LABORATORIES PUBL : Axim Nuclear & Oncology to supply RaySearch system..
AQ
06/24RAYSEARCH LABORATORIES PUBL : Three North African cancer centers place orders fo..
AQ
More news
Financials
Sales 2020 779 M 89,0 M 89,0 M
Net income 2020 66,5 M 7,60 M 7,60 M
Net cash 2020 15,0 M 1,71 M 1,71 M
P/E ratio 2020 41,3x
Yield 2020 0,38%
Capitalization 2 732 M 312 M 312 M
EV / Sales 2020 3,49x
EV / Sales 2021 2,96x
Nbr of Employees 396
Free-Float 69,7%
Chart RAYSEARCH LABORATORIES AB (PUBL)
Duration : Period :
RaySearch Laboratories AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RAYSEARCH LABORATORIES AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 93,50 SEK
Last Close Price 79,70 SEK
Spread / Highest target 19,2%
Spread / Average Target 17,3%
Spread / Lowest Target 15,4%
EPS Revisions
Managers
NameTitle
Johan Löf President, Chief Executive Officer & Director
Lars Micael Wollung Chairman
Peter Thysell Chief Financial Officer
Kjell Eriksson Chief Research Officer
Carl Filip Bergendal Director
Sector and Competitors
1st jan.Capitalization (M$)
RAYSEARCH LABORATORIES AB (PUBL)-25.65%312
VEEVA SYSTEMS INC.106.70%43 853
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED129.44%35 817
OMNICELL, INC.2.34%3 576
SECTRA AB (PUBL)56.39%2 687
PRO MEDICUS LIMITED52.66%2 528